Filter Results:
(1,056)
Show Results For
- All HBS Web
(1,056)
- People (2)
- News (291)
- Research (602)
- Multimedia (12)
- Faculty Publications (250)
Show Results For
- All HBS Web
(1,056)
- People (2)
- News (291)
- Research (602)
- Multimedia (12)
- Faculty Publications (250)
- Article
A Public Option Can Be a Triple Win for U.S. Healthcare
By: Regina E. Herzlinger and Richard Boxer
The United States needs to control healthcare costs and quality while reaching universal coverage. The strongest choice is a public option that allows people to choose between Medicare and private payers. But a public option needs sustainable financing mechanisms that... View Details
Keywords: Healthcare; Public Option; Universal Health Coverage; Health Care and Treatment; Cost Management; Quality; United States
Herzlinger, Regina E., and Richard Boxer. "A Public Option Can Be a Triple Win for U.S. Healthcare." Health Management, Policy and Innovation 4, no. 3 (December 2019).
- Web
Geography of Care - Institute For Strategy And Competitiveness
care. Partnering with Banner Health Care in Arizona, Cooper University Health Care in New Jersey, Baptist Health View Details
- Web
Health Care Curriculum - Institute For Strategy And Competitiveness
Cancer Center are the subject of cases, but there are cases on smaller providers and community hospitals as well. Cases include not only U.S. organizations, but also providers... View Details
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- 04 Mar 2014
- News
40 of the Smartest People in Healthcare
- Web
Kraft Precision Medicine Accelerator - Health Care
Faculty & Research Kraft Precision Medicine Accelerator About the Kraft Precision Medicine Accelerator From 2015–2020, the Harvard Business School Kraft Precision Medicine Accelerator (KPMA) worked to create... View Details
- Web
THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement
Sutter Author Health Care Initiative Team tag Care Delivery Health Care at HBS The Physician Shadow Program, sponsored by View Details
- February 2017 (Revised February 2021)
- Case
Hebrew SeniorLife: Next Steps
By: Regina E. Herzlinger, Carin-Isabel Knoop and Olivia Hull
The CEO of Hebrew SeniorLife is contemplating how to scale his highly successful but asset-intensive continuing care retirement community for elders. Among the strategies he is considering is an expansion to China; virtual web-based care; providing continuing care in... View Details
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
government's role in U.S. healthcare? What do you think? To Read More: Robert H. Frank, "A Health Care Plan So Simple, Even Stephen Colbert Couldn't Simplify It," View Details
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- Web
U.S. Competitiveness Project - Institute For Strategy And Competitiveness
Delivery Project The Institute for Cancer Care Innovation MOC Network ICIC U.S. Cluster Mapping Project U.S.... View Details
- September 2022
- Technical Note
Addressing Social Determinants of Health in the American Landscape
By: Susanna Gallani and Jacob Riegler
Social determinants of health (SDOH) have gained significant attention in recent years. A growing body of research shows that a person’s health is influenced by a large number of non-genetic factors, most of which operate outside the realm of health care and are... View Details
Keywords: Socioeconomic Determinants Of Health; Social Determinants Of Health; Population Health; Health; Health Care and Treatment; Social Issues; Health Industry; Insurance Industry; Medical Devices and Supplies Industry; United States
Gallani, Susanna, and Jacob Riegler. "Addressing Social Determinants of Health in the American Landscape." Harvard Business School Technical Note 123-023, September 2022.
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
who focus on the care of the patient with breast cancer, would support them. Ideally, they would be co-located in a single breast View Details
- November 2023
- Case
The Commons Project in Rwanda—Building Digital Infrastructure for the Global Public Good
By: Álvaro Rodríguez Arregui and Tom Quinn
In September 2022, The Commons Project Foundation (TCP) CEO Zhenya Lindgardt and her team met on a Zoom call to discuss building tools to help Rwandans manage their health data. They believed that helping Africa build digital infrastructure would improve much-needed... View Details
Keywords: Developing Countries and Economies; Capital; Cross-Cultural and Cross-Border Issues; Health Care and Treatment; Information Management; Adaptation; Information Infrastructure; Information Technology Industry; Rwanda; United States
Rodríguez Arregui, Álvaro, and Tom Quinn. "The Commons Project in Rwanda—Building Digital Infrastructure for the Global Public Good." Harvard Business School Case 824-026, November 2023.
- February 18, 2022
- Article
Transparency as a Solution for COVID-19 Related Hospital Capacity Issues
By: Regina E. Herzlinger and Richard Boxer
In the initial phases of the COVID-19 pandemic, many U.S. hospitals could not provide an adequate supply of beds to meet demand. Solving the problem of hospital bed capacity is of great importance in the “new normal,” which requires recognizing that SARS-CoV-2 is but... View Details
Keywords: COVID; COVID-19 Pandemic; Health Care; Health Care Demand; Health Care Delivery; Health Care Industry; Health Care Operations; Health Care Policy; Transparency; Hospital; Hospital Management; Hospitals; Health Pandemics; Health Care and Treatment; Service Delivery; Operations; Performance Capacity; Policy; Health Industry
Herzlinger, Regina E., and Richard Boxer. "Transparency as a Solution for COVID-19 Related Hospital Capacity Issues." Health Affairs Forefront (February 18, 2022).
- 23 Feb 2011
- News
Clayton Christensen: The Survivor
- 2015
- Other Teaching and Training Material
Innovating in Healthcare
By: Regina E. Herzlinger, Margo I. Seltzer and Kevin Schulman
With over 71,000 past enrollees, Innovating in Healthcare investigates the issues of health care spending, quality, and access that continue to plague America and global nations alike. With U.S. health care costs trending toward $4 trillion in 2020, the need to... View Details
Herzlinger, Regina E., Margo I. Seltzer, and Kevin Schulman. "Innovating in Healthcare." edX Inc., 2015. Video. (HarvardX Massive Open Online Course.)
- 2010
- Article
Estimating the Attributable Cost of Physician Burnout in the United States
By: Shasha Han, Tait D. Shanafelt, Christine A. Sinsky, Karim M. Awad, Liselotte N. Dyrbye, Lynne C. Fiscus, Mickey Trockel and Joel Goh
Background: Although physician burnout is associated with negative clinical and organizational outcomes, its economic costs are poorly understood. As a result, leaders in health care cannot properly assess the financial benefits of initiatives to remediate... View Details
Keywords: Physicians; Burnout; Health; Health Care and Treatment; Employees; Cost; Programs; Policy; Health Industry
Han, Shasha, Tait D. Shanafelt, Christine A. Sinsky, Karim M. Awad, Liselotte N. Dyrbye, Lynne C. Fiscus, Mickey Trockel, and Joel Goh. "Estimating the Attributable Cost of Physician Burnout in the United States." Annals of Internal Medicine 170, no. 11 (June 4, 2019): 784–790.
- 01 Feb 2001
- News
The Doctor Is In
finance, it seems, are never far from the minds of anyone in health care these days, even at fiscally sound MGH, the Harvard-affiliated teaching... View Details
- 05 May 2016
- News